Anti-apoptotic use of human glutaminyl-tRNA synthetase with...

Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Transferases

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S002600, C514S012200, C514S04400A, C435S183000, C435S194000

Reexamination Certificate

active

06548060

ABSTRACT:

FIELD OF THE INVENTION
This invention relates to novel anti-apoptotic use of human glutaminyl-tRNA synthetase with two consecutive pro-apoptotic mediators, that are ASK1 and Daxx.
BACKGROUND OF THE INVENTION
Apoptosis is a normal physiologic process that leads to individual cell death. This process of programmed cell death is involved in a variety of normal and pathogenic biological events and can be induced by a number of unrelated stimuli. Changes in the biological regulation of apoptosis also occur and diseases related to aging. Recent studies of apoptosis have implied that a common metabolic pathway leading to cell death may be initiated by a wide variety of signals, inducing hormones, serum growth factor deprivation, chemotherapeutic agents, ionizing radiation and infection by human immunodeficiency virus(HIV).
While apoptosis is a normal cellular event, it can also be induced by pathological conditions and a variety of injuries. Apoptosis is involved in a wide variety of conditions including but not limited to, cardiovascular disease, cancer regression, immunoregulation, viral diseases, anemia, neurological disorders, gastrointestinal disorders, including but not limited to, diarrhea and dysentery, diabetes, hair loss, rejection of organ trnasplants, prostate hypertrophy, obesity, ocular disorders, stress and aging.
Aminoacyl-tRNA synthetases (ARSs) play an essential role in protein synthesis, decoding genetic information into amino acids. These enzymes were generated early in evolution and accumulated a wide range of structural and functional diversity. The structural difference is not only observed between different ARSs but also between the same ARSs of different phylogenetic kingdoms (1). ARSs of higher eukaryotes have adopted many peculiar features in their structure and behavior distinguishable from those of prokaryotes (2-4).
For instance, some ARSs are functionally linked to apoptosis. Human tyrosyl-tRNA synthetase is released from the cell upon apoptosis and split into two distinct pro-apoptotic cytokines (5). The precursor of pro-apoptotic cytokine, EMAPII (endothelial monocyte activating polypeptide II) is associated with the N-terminal non-catalytic extension of arginyl-tRNA synthetase to facilitate aminoacylation (6). The C-terminal cytokine domain of this precursor is released by an apoptotic signal and exerts its pro-apoptotic function (7).
SUMMARY OF THE INVENTION
Aminoacyl-tRNA synthetases are the enzymes catalyzing ligation of their cognate amino acids and tRNAs. Human glutaminyl-tRNA synthetase (QRS) consists of the unique N-terminal extension (236 aa) and the C-terminal catalytic domain (539 aa). Here, we found that the N- and C-domains of QRS interacted with pro-apoptotic mediator, Daxx, and its downstream kinase, ASK1 (apoptosis signal-regulating kinase), respectively. The experimental results suggest that QRS may inhibit the ASK1 activity via two different ways. First, its C-terminal domain made direct inhibitory interaction with ASK1. Second, it inhibited the pro-apoptotic interaction between Daxx and ASK1. QRS also blocked the Daxx-ASK1 mediated apoptosis. Thus, QRS plays a regulatory role in apoptosis and thus can be used to control cell death.


REFERENCES:
patent: 6159731 (2000-12-01), Yang et al.
Shiba, et al.,Maintaining genetic code through adaptations of tRNA synthetases to taxonomic domains, Trends Biochem. Sci, 1997, 22:453-457.
Marc Mirande,Aminoacyl-tRNA Synthetase Family from Prokaryotes and Eukaryotes: Structural Domains and Their Implications, Prog. Nucleic Acid Res. Mol. Biol., 1991, 40:95-142.
Kisselev & Wolfson,Aminoacyl-tRNA Synthetases form Higher Eukaryotes, Prog. Nucleic Acid Res. Mol. Biol., 1994, 48:83-142.
David Yang,Mammalian Aminoacyl-tRNA Synthetases, Current Topics in Cellular Regulation, 1996, 34:101-136.
Wakasugi & Schimmel,Two Distinct Cytokines Released from a Human Aminoacyl-tRNA Synthetase, Science, 1999, 248:147-151.
Park et al.,Precursor of Pro-apoptotic Cytokine Modulates Aminoacylation Activity of tRNA Synthetase, J. Biol. Chem., 1999, 274(24):16673-16676.
Knies et al.,Regulation of endothelial monocyte-activating polypeptide ll release by apoptosis, Proc. Natl. Acad. Sci. USA, 1998, 95:12322-12327.
Rho et al.,Genetic dissection of protein-protein interactions in multi-tRNA synthetase complex, Proc. Natl. Acad. Sci. USA, 1999, 96:4488-4493.
Gyuris et al.,Cdi1, a Human G1 and S Phase Protein Phosphatase That Associates with Cdk2, Cell, 1993, 75:791-803.
Yang et al.,Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosis, Cell, 1997, 89:1067-1076.
Chang et al.,Activation of Apoptosis Signal-Regulating Kinase 1 (ASK1) by the Adapter Protein Daxx, Science, 1998, 281:1860-1863.
Ichijo et al.,Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways, Science, 1997, 275:90-94.
Saitoh et al.,Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1, The Embo J., 1998, 17(9):2596-2606.
Hollenbach, et al.,The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx, The Embo J., 1999, 18(13): 3702-3711.
Pluta, et al.,Interphase-specific association of intrinsic centromere protein CENP-C with HDaxx, a death domain-binding protein implicated in FAS-mediated cell death, J. Cell. Sci., 1998, 111:2029-2041.
Roh et al.,A Multifunctional Repeated Motif Is Present in Human Bifunctional tRNA Synthetase, J.. Biol. Chem., 1998, 273(18): 11267-11273.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-apoptotic use of human glutaminyl-tRNA synthetase with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-apoptotic use of human glutaminyl-tRNA synthetase with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-apoptotic use of human glutaminyl-tRNA synthetase with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3102208

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.